AGIOS PHARMACEUTICALS INC's ticker is and the CUSIP is 00847X904. A total of 4 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,108,184 | +61.3% | 25,700 | +9.4% | 0.00% | – |
| Q1 2024 | $687,140 | +116.6% | 23,500 | +109.8% | 0.00% | – |
| Q2 2023 | $317,184 | -62.8% | 11,200 | -69.8% | 0.00% | – |
| Q1 2023 | $852,187 | -66.7% | 37,100 | -59.3% | 0.00% | -100.0% |
| Q4 2022 | $2,558,088 | +63.2% | 91,100 | +64.4% | 0.00% | 0.0% |
| Q3 2022 | $1,567,000 | +2.3% | 55,400 | -19.8% | 0.00% | 0.0% |
| Q2 2022 | $1,532,000 | – | 69,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 69,100 | $1,532,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,000 | $67,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 18,900 | $419,000 | 0.00% |